slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 22,741-22,770
Pages 1,437
Rows per page 30
Arc
22,741-22,770 of 43,093
05
Nextdoor | Investor Presentation Deck | 34 slidesNextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Traction1 hit
06
The slide uses a human-centric photo of a local shopkeeper to reinforce the 'local business' and 'community' themes.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Traction1 hit
13
Uses a concentric circle diagram to represent TAM/SAM/SOM-style market expansion.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
14
The slide uses a bubble-in-bubble visualization to represent U.S. vs Global TAM.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
15
The chart uses a Marimekko layout to visualize the total addressable monetization potential (area of the rectangles) for each platform.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
16
The slide uses a split-screen layout with a product screenshot on the left and key metrics on the right.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
23
Nextdoor | Investor Presentation Deck | 34 slidesNextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Team1 hit
24
Nextdoor | Investor Presentation Deck | 34 slidesNextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Team1 hit
26
Nextdoor | Investor Presentation Deck | 34 slidesNextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
27
The slide uses a CAGR metric to highlight growth trends over specific periods.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
28
The slide uses two bar charts side-by-side to demonstrate consistent revenue growth over time.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
29
The slide shows two distinct bar charts side-by-side, one for annual data and one for quarterly data, with CAGR percentages highlighted.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
03
NextNav | Results Presentation Deck | 9 slidesNextNav | Results Presentation Deck | 9 slides · NextNav
Conference presentation Investor relations Beat · Problem1 hit
04
Visualizes frequency spectrum allocation with specific MHz markers.NextNav | Results Presentation Deck | 9 slides · NextNav
Conference presentation Investor relations Beat · Problem1 hit
05
The slide is split into two sections: specific device integrations on the left and a logo grid of public safety partners on the right.NextNav | Results Presentation Deck | 9 slides · NextNav
Conference presentation Investor relations Beat · Solution1 hit
06
The slide uses a map of Europe to contextualize the European Commission JRC report.NextNav | Results Presentation Deck | 9 slides · NextNav
Conference presentation Investor relations Beat · Solution1 hit
08
The slide uses a hub-and-spoke diagram to organize six key investment pillars around the company logo.NextNav | Results Presentation Deck | 9 slides · NextNav
Conference presentation Investor relations Beat · Financials1 hit
06
Uses a Venn diagram to illustrate the intersection of two key clinical challenges.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · Solution1 hit
07
Uses a visual process flow to contrast existing therapy failure with Nuvalent's solution.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide highlights the clinical need for new therapies due to resistance mutations (G2032R) and CNS involvement.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
11
The table uses a green background to indicate positive results ('Yes') and white for negative results ('No').Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · CompetitionLoop · Cost Of Inaction1 hit
13
The slide uses dot plots for IC50 data and a bar chart for in vivo efficacy, highlighting NVL-520's performance.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
14
The slide uses two distinct chart types to demonstrate efficacy: a bar chart for brain penetrance and a grouped bar chart for selectivity index.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
Includes a detailed table of Phase 2 cohorts and a list of study objectives.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
16
The slide details the transition from the All-Treated Population (N=35) to the NSCLC Response-Evaluable Population (N=21) through back-fill expansion.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
17
Data table showing demographics, tumor types, ECOG performance status, and prior treatment history including specific TKI therapies.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
18
Data as of 13 Sep 22. Table lists specific adverse events by grade.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
19
The chart displays dose-dependent exposure levels exceeding multiple target thresholds for ROS1 variants in CNS and periphery.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
20
Clinical trial data table showing efficacy metrics for a drug candidate.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
21
The chart uses a waterfall plot to visualize clinical efficacy, a standard in oncology drug development.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit